Mechanism · Immunology
GPCR autoantibodies
Some of the most disruptive long COVID symptoms may come from the immune system attacking the body's own control switches. Functional autoantibodies against the receptors that govern heart rate and vessel tone are found at high rates in some cohorts, offering a direct route from immune trouble to dysautonomia.
Short version: in a subset of people, antibodies bind the receptors that control heart rate and blood pressure and jam them. Whether they cause symptoms or travel with them is still being established.
Antibodies aimed at the body's own switches
G-protein-coupled receptors are the switches that hormones and nerves use to set heart rate and vessel tone. In a subset of long COVID, the immune system makes antibodies that bind these switches directly and hold them on or off.1
What has been measured
Studies report functional autoantibodies against adrenergic, angiotensin, and muscarinic receptors, present at strikingly high rates in some long COVID cohorts. They are not just markers; in the lab they can change how the receptors behave.1, 2
well-founded for a subset causation contested
The honest limit
Similar autoantibodies appear in healthy people too, so finding them does not prove they cause symptoms. The question of marker versus driver is unsettled, and this page says so rather than overselling.2
Why it matters anyway
It offers a concrete route from immune trouble to dysautonomia, POTS, and labile blood pressure, and it is why therapies that remove or block antibodies are being studied.
What we don't know
Honest about the edges of the evidence. These are open questions, not settled answers.
- Whether these autoantibodies cause symptoms or are bystanders.
- Why similar autoantibodies appear in some healthy people.
- Whether removing or blocking them relieves symptoms, which trials are testing.
- Which receptor targets matter most.
- How they arise after infection.
References
Every reference is free to read in full.